|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/46 | |
| A61K 9/00 | |||
| A61K 9/12 | |||
| A61P 11/00 | |||
| A61K 47/10 | |||
| A61K 47/12 | |||
| A61M 15/00 |
| (11) | Patento numeris | 3143998 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16185402.1 |
| Europos patento paraiškos padavimo data | 2012-12-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161577315 P | 2011-12-19 | US | |
| 201200525 | 2012-01-13 | GB |
| (72) |
ZENG, Xian-Ming, US
|
| (73) |
Teva Branded Pharmaceutical Products R & D, Inc.,
41 Moores Road, Frazer, Pennsylvania 19355,
US
|
| (54) | AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM |
| AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM |